Migraine Relief Tablet
Product Images NDC 43689-0017

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Migraine Relief (NDC 43689-0017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The Magni Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Migraine Relief 5-19-15 Lbl (Mgni0001 Migraine Relief 5 19 15)

This is a drug facts label for Migraine Relief tablets that are intended to relieve symptoms associated with migraine headaches, including headaches, noise sensitivity, and other symptoms. The label includes information about warnings and usage, but no specific dosing instructions are provided. There is also a warning indicating that additional information is available via a website called "maglfe com."*

FDA Label Image

Mgni0006 Migraine Relief Ctn 9 16 19

MAGNILIFE Migraine Relief is a medication that aims to relieve the symptoms of migraine headaches such as light and noise sensitivity, blurred vision, and nausea. It is a tablet that dissolves under the tongue and has no known contraindications or side effects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.